Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple zap to the neck cure sleep apnoea?

NCT ID NCT07396649

Symptom relief Sponsor: Notos Medical Limited Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a non-invasive electrical stimulation device can help people with obstructive sleep apnoea breathe easier during sleep. Fifteen adults with moderate to severe sleep apnoea will wear sticky electrodes under their chin while sleeping. The goal is to see if they can tolerate the stimulation without waking up.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
non-invasive electrical nerve stimulation device
What this could lead to
If successful, this could lead to a new, non-invasive way to treat sleep apnoea without a mask or surgery.
What could go wrong
This is a very small, early-stage trial with only 15 people, so results may not apply to everyone. The stimulation might cause discomfort or awakenings during sleep.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 15 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Obstructive sleep apnoea diagnosis with an AHI of 15-50 events/hour recorded in the baseline polysomnography (PSG) * BMI \< 32 kg/m² * Age \> 18 years old * Able to read, write, and speak Dutch with acceptable visual and auditory acuity * Able and willing to provide informed consent Exclusion Criteria: * Presence of a cardiac pacemaker or implantable cardiac defibrillator or ventriculoperitoneal shunt * Central (non-obstructive) AHI episodes \>5 events/hour recorded in the baseline PSG * Inability to sleep supine * Pregnancy * Inability to undergo DISE * Inability or unwillingness to shave under and around their chin and neck if appropriate * Known inability to complete PSG with a total sleep time of \> 4 hours * The use of other neurostimulatory devices * A diagnosis of periodic leg movement disorder * Awake resting arterial oxygen saturation \<93% (suggesting possible hypoventilation) * Unstable, untreated coronary or peripheral artery disease * Severe arterial hypertension defined as a resting blood pressure (BP) of \>180/110mmHg * Currently employed as a professional driver * Any previous sleep-related driving accident * A past or current condition that in the opinion of the investigator contraindicates enrolment (e.g. chronic substance abuse, severe psychiatric disorders)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obstructive sleep apnoea (OSA) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obstructive sleep apnoea (OSA)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Antwerp University Hospital

    RECRUITING

    Edegem, 2650, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.